Groupe la Francaise’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.1M Buy
75,630
+1,600
+2% +$107K 0.06% 185
2026
Q1
$4.63M Sell
74,030
-24,693
-25% -$1.72M 0.06% 195
2025
Q4
$6.55M Buy
98,723
+9,528
+11% +$616K 0.09% 142
2025
Q3
$6.01M Buy
89,195
+12,169
+16% +$963K 0.08% 140
2025
Q2
$6.69M Buy
77,026
+36,180
+89% +$2.84M 0.11% 122
2025
Q1
$2.84M Buy
40,846
+3,288
+9% +$268K 0.06% 202
2024
Q4
$3M Buy
+37,558
New +$2.78M 0.07% 155

Other funds holding DXCM

Groupe la Francaise's DXCM Position: Q2 2026 in Review

Groupe la Francaise increased its DexCom (DXCM) stake by 2.2% in Q2 2026, buying an estimated $107K and bringing the position to 75,630 shares worth $5.1M. The position accounts for 0.06% of the portfolio, ranked #185.

Groupe la Francaise first reported a position in DXCM in Q4 2024 and has held it in 7 quarters since. The position peaked at $6.69M in Q2 2025. 976 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Groupe la Francaise held 75,630 shares of DexCom worth $5.1M as of Q2 2026.
  • Groupe la Francaise bought 1,600 DexCom shares in Q2 2026, an estimated $107K.
  • DexCom made up 0.06% of Groupe la Francaise's portfolio in Q2 2026, its #185 holding.
  • Groupe la Francaise first reported a position in DexCom in Q4 2024 and has held it in 7 quarters since.
  • Groupe la Francaise's DexCom position peaked at $6.69M in Q2 2025.
  • 976 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Groupe la Francaise's 13F filing for Q2 2026, filed 25 Aug 2026.